ACUTAAS CHEMICALS
|
ACUTAAS CHEMICALS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 43.51 | 19.39 | 11.60 | 22.86 | 19.75 |
| CEPS(Rs) | 47.92 | 11.42 | 8.78 | 13.12 | 11.26 |
| DPS(Rs) | 2.50 | 1.50 | 3.00 | 3.00 | 3.00 |
| Book NAV/Share(Rs) | 201.59 | 159.95 | 182.13 | 163.01 | 143.34 |
| Tax Rate(%) | 26.18 | 25.79 | 40.53 | 25.75 | 21.33 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 35.87 | 23.05 | 17.91 | 19.88 | 20.22 |
| EBIT Margin(%) | 36.29 | 22.09 | 12.24 | 18.58 | 18.81 |
| Pre Tax Margin(%) | 36.04 | 21.47 | 11.42 | 18.19 | 17.58 |
| PAT Margin (%) | 26.61 | 15.93 | 6.79 | 13.50 | 13.83 |
| Cash Profit Margin (%) | 29.29 | 18.58 | 9.03 | 15.51 | 15.77 |
| Performance Ratios | |||||
| ROA(%) | 20.17 | 12.13 | 5.23 | 11.68 | 13.42 |
| ROE(%) | 24.08 | 16.19 | 7.70 | 14.92 | 21.07 |
| ROCE(%) | 32.42 | 20.14 | 11.81 | 20.45 | 23.85 |
| Asset Turnover(x) | 0.76 | 0.76 | 0.77 | 0.87 | 0.97 |
| Sales/Fixed Asset(x) | 1.77 | 1.78 | 1.84 | 2.33 | 2.40 |
| Working Capital/Sales(x) | 2.06 | 1.71 | 3.45 | 2.10 | 1.73 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.57 | 0.56 | 0.54 | 0.43 | 0.42 |
| Receivable days | 88.98 | 90.06 | 111.06 | 116.58 | 99.79 |
| Inventory Days | 56.04 | 61.02 | 70.18 | 68.46 | 60.54 |
| Payable days | 99.95 | 96.06 | 122.64 | 143.66 | 135.92 |
| Valuation Parameters | |||||
| PER(x) | 58.79 | 62.97 | 47.18 | 19.44 | 50.63 |
| PCE(x) | 53.38 | 106.87 | 62.32 | 33.87 | 44.41 |
| Price/Book(x) | 12.69 | 15.26 | 6.01 | 5.45 | 6.97 |
| Yield(%) | 0.10 | 0.06 | 0.27 | 0.34 | 0.30 |
| EV/Net Sales(x) | 15.49 | 19.61 | 5.85 | 5.16 | 6.81 |
| EV/Core EBITDA(x) | 39.75 | 79.31 | 30.88 | 25.09 | 32.83 |
| EV/EBIT(x) | 42.69 | 88.80 | 47.81 | 27.79 | 36.21 |
| EV/CE(x) | 12.35 | 14.99 | 4.71 | 5.33 | 6.77 |
| M Cap / Sales | 15.64 | 19.85 | 5.63 | 5.25 | 7.00 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 33.02 | 40.34 | 16.33 | 18.57 | 52.71 |
| Core EBITDA Growth(%) | 109.63 | 83.12 | 7.13 | 17.59 | 32.39 |
| EBIT Growth(%) | 118.54 | 153.16 | -23.34 | 17.09 | 26.52 |
| PAT Growth(%) | 122.15 | 229.35 | -41.52 | 15.77 | 33.24 |
| EPS Growth(%) | 124.46 | 67.16 | -49.26 | 15.77 | 15.18 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.01 | 0.32 | 0.01 | - |
| Current Ratio(x) | 3.82 | 3.91 | 1.73 | 2.81 | 3.32 |
| Quick Ratio(x) | 2.82 | 3.02 | 1.18 | 2.08 | 2.45 |
| Interest Cover(x) | 148.71 | 35.76 | 14.79 | 47.50 | 15.27 |
| Total Debt/Mcap(x) | - | - | 0.05 | - | - |
Compare Financial Ratios of peers of ACUTAAS CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ACUTAAS CHEMICALS | ₹27,660.5 Cr | 6.2% | 8.6% | 135.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
ACUTAAS CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ACUTAAS CHEMICALS | 6.2% |
8.6% |
135.1% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses
